Page 393 - ATP-P 11th Ed

iii. If possible, gently rinse the eye with clean water
iv. Ensure that oral or IV/IM antibiotics are given as outlined below.
Ketamine can cause nystagmus and increased intraocular pressure in a MWD.
Therefore consider alternative sedatives/analgesics in MWDs with penetrating eye
traumas unless other alternatives do not exist or are ineffective.
9. Monitoring
a. Initiate advanced electronic monitoring if indicated and if monitoring equipment
is available.
i. Monitors of choice include pulse oximetry (placed on the lip, tongue or pre-
puce) and capnography if intubated
10. Analgesia
a. Analgesia on the battlefield should generally be achieved using 1 of 3 options:
Option 1
i. Mild to Moderate Pain
(a) Meloxicam – ½ of a 7.5mg tablet (0.1mg/kg) PO once a day
(b) DO NOT give Tylenol or ibuprofen to an MWD
Option 2
i. Moderate to Severe Pain
(a) MWD IS NOT in shock or respiratory distress AND
(b) MWD IS NOT at significant risk of developing either condition
(c) Do not attempt to give Oral transmucosal fentanyl citrate (OTFC) to an
MWD. Rather administer ONE of the below options:
• Morphine at 0.25-0.5mg/kg IM (equivalent to one 10mg morphine SECTION 4
auto injector) or
• Hydromorphone 0.1mg/kg IV/IO/IM or
• Fentanyl (injectable) q20–30min at:
♦ 2–5mcg/kg IV/IO
♦ 10mcg/kg IM
♦ 4mcg/kg IN (Intranasal)
Morphine and hydromorphone often causes vomiting in dogs so handlers and medics
should be prepared to remove the muzzle after administration of an opioid. Hydromor-
phone causes excessive panting; use caution with head injuries and respiratory disease.

Option 3
i. Moderate to Severe Pain
(a) MWD IS in hemorrhagic shock or respiratory distress OR
(b) MWD IS at significant risk of developing either condition
(c) Ketamine 2–5mg/kg (60–90mg) IV/IO/IM/IN

ATP-P Handbook 11th Edition 383